Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$105.40 +0.5%	$103.63	$71.88 ▼ $108.94	$155.22B	0.66	7.45 million shs	6.34 million shs
EW Edwards Lifesciences	$79.30 0.0%	$76.91	$59.41 ▼ $83.00	$46.52B	1.08	4.90 million shs	3.15 million shs
MDT Medtronic	$89.31 -1.0%	$87.76	$79.29 ▼ $96.25	$115.74B	0.8	6.48 million shs	6.51 million shs
SYK Stryker	$378.62 -3.6%	$387.46	$314.93 ▼ $406.19	$149.90B	0.91	1.16 million shs	3.01 million shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	+0.50%	-0.63%	+1.77%	+0.44%	+42.70%
EW Edwards Lifesciences	-0.01%	-0.77%	+2.95%	+4.94%	+25.79%
MDT Medtronic	-1.02%	-3.87%	+1.01%	+5.39%	+11.19%
SYK Stryker	-3.75%	-6.13%	-3.41%	+0.01%	+15.63%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BSX Boston Scientific	4.538 of 5 stars	3.5	3.0	0.0	4.2	3.4	2.5	1.3
EW Edwards Lifesciences	4.4846 of 5 stars	2.3	4.0	0.0	4.0	3.3	2.5	2.5
MDT Medtronic	4.5616 of 5 stars	2.3	3.0	3.3	4.1	3.7	1.7	1.9
SYK Stryker	4.9234 of 5 stars	3.4	5.0	3.3	4.2	3.4	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSX Boston Scientific	3.04	Buy	$117.50	11.48% Upside
EW Edwards Lifesciences	2.65	Moderate Buy	$85.71	8.09% Upside
MDT Medtronic	2.59	Moderate Buy	$98.19	9.94% Upside
SYK Stryker	2.79	Moderate Buy	$429.35	13.40% Upside

Current Analyst Ratings Breakdown

Latest EW, BSX, SYK, and MDT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/1/2025	SYK Stryker	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$435.00 ➝ $445.00
8/1/2025	SYK Stryker	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$442.00 ➝ $448.00
7/29/2025	EW Edwards Lifesciences	Daiwa America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/29/2025	EW Edwards Lifesciences	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$100.00
7/25/2025	EW Edwards Lifesciences	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
7/25/2025	EW Edwards Lifesciences	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/25/2025	EW Edwards Lifesciences	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$80.00 ➝ $85.00
7/25/2025	EW Edwards Lifesciences	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$75.00 ➝ $81.00
7/25/2025	EW Edwards Lifesciences	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$87.00 ➝ $95.00
7/25/2025	EW Edwards Lifesciences	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$81.00 ➝ $82.00
7/25/2025	EW Edwards Lifesciences	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$83.00 ➝ $90.00

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSX Boston Scientific	$16.75B	9.31	$3.67 per share	28.74	$14.93 per share	7.06
EW Edwards Lifesciences	$5.44B	8.55	$2.73 per share	29.05	$17.06 per share	4.65
MDT Medtronic	$33.54B	3.42	$7.67 per share	11.64	$37.62 per share	2.37
SYK Stryker	$22.60B	6.40	$14.54 per share	26.04	$54.13 per share	6.99

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSX Boston Scientific	$1.85B	$1.68	62.74	32.63	2.53	13.55%	19.39%	10.78%	N/A
EW Edwards Lifesciences	$4.17B	$6.95	11.41	28.84	3.84	72.96%	15.25%	11.66%	N/A
MDT Medtronic	$4.66B	$3.62	24.67	15.32	2.34	13.90%	14.54%	7.83%	8/19/2025 (Estimated)
SYK Stryker	$2.99B	$7.40	50.15	25.53	2.91	12.25%	24.12%	11.21%	N/A

Latest EW, BSX, SYK, and MDT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2025	Q1 2026	MDT Medtronic	$1.23	N/A	N/A	N/A	$8.37 billion	N/A
7/31/2025	Q2 2025	SYK Stryker	$3.07	$3.13	+$0.06	$2.29	$5.92 billion	$6.02 billion
7/24/2025	Q2 2025	EW Edwards Lifesciences	$0.62	$0.67	+$0.05	$0.56	$1.49 billion	$1.53 billion
7/23/2025	Q2 2025	BSX Boston Scientific	$0.72	$0.75	+$0.03	$0.53	$4.89 billion	$5.06 billion
5/21/2025	Q4 2025	MDT Medtronic	$1.58	$1.62	+$0.04	$0.82	$8.81 billion	$8.93 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
EW Edwards Lifesciences	N/A	N/A	N/A	N/A	N/A
MDT Medtronic	$2.84	3.18%	N/A	78.45%	49 Years
SYK Stryker	$3.36	0.89%	N/A	45.41%	32 Years

Latest EW, BSX, SYK, and MDT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/8/2025	SYK Stryker	quarterly	$0.84	0.88%	6/30/2025	6/30/2025	7/31/2025
5/21/2025	MDT Medtronic	quarterly	$0.71	3.3%	6/27/2025	6/27/2025	7/11/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSX Boston Scientific	0.47	1.45	0.88
EW Edwards Lifesciences	0.06	4.45	3.66
MDT Medtronic	0.53	1.85	1.42
SYK Stryker	0.69	1.64	1.00

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSX Boston Scientific	89.07%
EW Edwards Lifesciences	79.46%
MDT Medtronic	82.06%
SYK Stryker	77.09%

Insider Ownership

Company	Insider Ownership
BSX Boston Scientific	0.50%
EW Edwards Lifesciences	1.29%
MDT Medtronic	0.20%
SYK Stryker	5.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSX Boston Scientific	53,000	1.48 billion	1.47 billion	Optionable
EW Edwards Lifesciences	15,800	586.60 million	579.03 million	Optionable
MDT Medtronic	95,000	1.28 billion	1.28 billion	Optionable
SYK Stryker	53,000	381.69 million	359.17 million	Optionable

EW, SYK, BSX, and MDT Headlines

Recent News About These Companies

Stryker (NYSE:SYK) Price Target Raised to $445.00

5 hours ago | marketbeat.com

Stryker (NYSE:SYK) Price Target Raised to $448.00 at Needham & Company LLC

August 2 at 8:28 AM | marketbeat.com

Commerce Bank Buys 2,822 Shares of Stryker Corporation (NYSE:SYK)

August 2 at 6:20 AM | marketbeat.com

Stryker Corporation (NYSE:SYK) Shares Acquired by Howland Capital Management LLC

August 2 at 5:47 AM | marketbeat.com

Vestcor Inc Has $2.37 Million Stock Holdings in Stryker Corporation (NYSE:SYK)

August 2 at 5:21 AM | marketbeat.com

Stryker (SYK) Q2 Revenue Jumps 11%

August 2 at 5:08 AM | fool.com

Beyond The Numbers: 4 Analysts Discuss Stryker Stock

August 2 at 3:54 AM | benzinga.com

Decoding Stryker Corp (SYK): A Strategic SWOT Insight

August 1 at 12:11 AM | gurufocus.com

Stryker Lifts Guidance on Improving Tariff Outlook

August 1 at 10:55 PM | wsj.com

Stryker (NYSE:SYK) Releases FY 2025 Earnings Guidance

August 1 at 4:31 PM | marketbeat.com

Stryker (SYK) Reports Q2 Earnings: What Key Metrics Have to Say

August 1 at 3:01 PM | zacks.com

SYK Stock Falls Despite Q2 Earnings & Sales Beat, '25 View Up

August 1 at 9:50 AM | zacks.com

Lyell Wealth Management LP Buys 3,260 Shares of Stryker Corporation (NYSE:SYK)

August 1 at 8:38 AM | marketbeat.com

Hoxton Planning & Management LLC Acquires New Stake in Stryker Corporation (NYSE:SYK)

August 1 at 8:36 AM | marketbeat.com

Natixis Advisors LLC Has $71.47 Million Stake in Stryker Corporation (NYSE:SYK)

August 1 at 8:24 AM | marketbeat.com

Stryker shares tumble despite strong Q2 results and raised guidance

August 1 at 2:12 AM | investing.com

Stryker ups guidance on Street-beating Q2, reduced tariff impact

August 1 at 2:12 AM | massdevice.com

1SYK : If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

August 1 at 2:12 AM | benzinga.com

Stryker (NYSE:SYK) Surprises With Q2 Sales But Stock Drops

August 1 at 2:12 AM | msn.com

Q2 2025 Stryker Corp Earnings Call Transcript

July 31 at 12:41 AM | gurufocus.com

Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript

July 31 at 11:02 PM | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

America Wants Drone Dominance: Are These Stocks Ready to Soar?
By Chris Markoch | July 20, 2025
View America Wants Drone Dominance: Are These Stocks Ready to Soar?
Super Micro Computer Sees Unusual Volume—Catalyst Ahead?
By Gabriel Osorio-Mazilli | July 25, 2025
View Super Micro Computer Sees Unusual Volume—Catalyst Ahead?
3 Catalysts Driving Plug Power’s Turnaround Case
By Jeffrey Neal Johnson | July 18, 2025
View 3 Catalysts Driving Plug Power’s Turnaround Case
Rivian Stock Rallies as Robotaxi Buzz Builds
By Gabriel Osorio-Mazilli | July 24, 2025
View Rivian Stock Rallies as Robotaxi Buzz Builds
5 Stocks to Buy and Hold for the Rise of Physical AI
By Thomas Hughes | July 23, 2025
View 5 Stocks to Buy and Hold for the Rise of Physical AI

EW, SYK, BSX, and MDT Company Descriptions

Boston Scientific NYSE:BSX

$105.40 +0.48 (+0.46%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$105.59 +0.19 (+0.18%)

As of 08/1/2025 07:40 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Edwards Lifesciences NYSE:EW

$79.30 -0.01 (-0.01%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$79.39 +0.09 (+0.11%)

As of 08/1/2025 07:17 PM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Medtronic NYSE:MDT

$89.31 -0.93 (-1.03%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$89.18 -0.14 (-0.15%)

As of 08/1/2025 07:58 PM Eastern

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Stryker NYSE:SYK

$378.62 -14.11 (-3.59%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$378.62 0.00 (0.00%)

As of 08/1/2025 07:54 PM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time